Early research (Phase 1)Looking for participantsNCT07044050
What this trial is testing
A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Who this might be right for
Diffuse Large B-cell Lymphoma With no Other Specification
Emercell SAS 10